Anzeige
Mehr »
Login
Donnerstag, 09.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
GameStop 2.0? ...alle Anzeichen für den nächsten großen Short Squeeze!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
537 Leser
Artikel bewerten:
(2)

Global Ambulatory Surgical Center Operating Room Integration Systems Market to Reach $5.66 Billion by 2032 - Exclusive DeepTech M-A-P Analysis by BIS Research

Finanznachrichten News

More and more surgeries are expected to shift to outpatient settings in the coming years owing to technological advancements in minimally invasive surgeries that enable faster procedures and quick recoveries.

FREMONT, Calif., Oct. 14, 2022 /PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Ambulatory Surgical Center Operating Room Integration Systems Market - A Global and Regional Analysis.

BIS_Research_Logo

According to this study, the market size of the global ambulatory surgical center (ASC) operating room integration systems market was valued at $2.07 billion in 2021 and is projected to reach $5.66 billion by 2032.

The following factors are responsible for the increase in demand for ASC operating room integration systems:

  • Benefits provided by OR integration, such as improved surgical workflows and better patient outcomes
  • Cost savings in ASCs benefit all stakeholders, including, but not limited to, patients, payers, and healthcare providers
  • Growing demand for outpatient care
  • Growing government support and funding to ASCs
  • Increasing patients' safety concerns in the OR

The detailed study is a compilation of 35 market data tables and 183 figures spread through 279 pages.

Check out the detailed table of content here

https://bisresearch.com/requestsample?id=1378&type=toc

Analyst's Take on the Market Projection

According to Satyendrsingh Rajput, Lead Analyst, BIS Research, "The COVID-19 pandemic accelerated the migration of surgeries from hospitals to outpatient facilities such as ASCs. This was owing to the unprecedented burden on hospitals and the various benefits of day surgeries in ASCs, such as shorter recovery times and improved patient outcomes."

Request a FREE sample of this report here

https://bisresearch.com/requestsample?id=1378&type=download

Existing Competitive Landscape

The companies that are profiled have been selected based on input gathered from primary experts and analyzing company coverage, product portfolio, and market penetration. Some of the established names in the market are Arthrex, Inc., Avante Health Solutions, Barco NV, Canon Inc., EIZO Corporation, FUJIFILM Holdings Corporation, General Electric Company, Getinge AB, KARL STORZ SE & Co. KG, Koninklijke Philips N.V., Olympus Corporation, Richard Wolf GmbH, Siemens Healthineers AG, STERIS plc, and Stryker Corporation.

Recent Developments in the Global Ambulatory Surgical Center Operating Room Integration Systems Market

  • In July 2022, Arthrex Inc. partnered with Skytron to expand operating room technology and infrastructure solutions for U.S. hospitals and surgical centers.
  • In April 2022, General Electric Company partnered with Medtronic to meet the growing needs for ambulatory surgery centers and office-based labs. Under this collaboration, customers can access extensive product portfolios, financial solutions, and exceptional service.
  • In January 2022, Philips Healthcare announced physicians would have access to advanced new 3D image guidance capabilities through its Image-Guided Therapy Mobile C-arm System Zenition.
  • In November 2021, Eizo expanded its product offering, CuratOR surgical panel, with 4K touchscreen surgical displays.
  • In July 2021, HillRom launched the Helion Integrated Surgical System in the U.S. to enhance connectivity and communication in the operating room and improve patient outcomes.

Single Specialty ASCs to Gain Momentum During the Forecast Period

Single-specialty ASCs are outpatient facilities focused on conducting surgical procedures relating to a single specialty. According to the study conducted by BIS Research, the benefits of ambulatory surgery centers are maximized in single-specialty settings. In single-specialty ASCs, physicians are primarily engaged in the same medical practice specialty.

Want to learn more about the latest trends in MedTech and the overall healthcare industry? Speak to our analysts

Exclusive DeepTech MAP Analysis For MedTech by BIS Research:

OR Integration Systems Market

About BIS Research:

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals.

Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

BIS Research offers syndicate as well as custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.

Contact:

Bhavya Banga
Email: media@bisresearch.com
+1-510-404-8135
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://bisresearch.com/news
Get Expert Insights @ https://community.insightmonk.com
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch

Logo: https://mma.prnewswire.com/media/495163/BIS_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/global-ambulatory-surgical-center-operating-room-integration-systems-market-to-reach-5-66-billion-by-2032--exclusive-deeptech-m-a-p-analysis-by-bis-research-301649413.html

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.